Composition comprising a PDE4 inhibitor and a PDE5 inhibitor

Details for Australian Patent Application No. 2004241749 (hide)

Owner Nycomed GmbH

Inventors Schudt, Christian; Dunkern, Thorsten; Ghofrani, Hossein Ardeschir; Hatzelmann, Armin; Grimminger, Friedrich

Agent Griffith Hack

Pub. Number AU-B-2004241749

PCT Pub. Number WO2004/103407

Priority 03011609.9 22.05.03 EP

Filing date 19 May 2004

Wipo publication date 2 December 2004

Acceptance publication date 25 March 2010

International Classifications

A61K 31/205 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/522 (2006.01)

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/103407 Priority application(s): WO2004/103407

22 November 2007 Change of Name(s) of Applicant(s), Section 104

  ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH

25 March 2010 Application Accepted

  Published as AU-B-2004241749

22 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004241756-A matrix band

2004241748-Glycosaminoglycans for treatment emotional dysfunctions